31 studies found for:    " November 21, 2012":" December 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 21, 2012":" December 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
2 Active, not recruiting Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care
Condition: HIV Positive Youth That Are Newly Engaged in Care.
Interventions: Behavioral: Project ACCEPT;   Behavioral: HEALTH
3 Unknown  Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence
Conditions: Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS);   Self-Directed Violence
Intervention:
4 Terminated A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid;   Drug: tenofovir DF 300 mg qd
5 Withdrawn A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid
6 Recruiting Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART
Condition: HIV Infection
Interventions: Dietary Supplement: Vitamin D3 50,000 IU;   Dietary Supplement: Vitamin D3 placebo
7 Completed A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 30 mg oral;   Drug: Midazolam 3 mg oral + GSK1265744 30mg oral;   Drug: GSK1265744 400 mg (200 nm);   Drug: GSK1265744 400 mg (1 micro m);   Drug: GSK1265744 400 mg (5 micro m)
8 Completed A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
9 Recruiting A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista
Condition: Acquired Immune Deficiency Syndrome
Intervention: Drug: No intervention
10 Completed Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda.
Condition: HIV
Interventions: Procedure: Shang Ring Guided Circumcision;   Procedure: Forceps Guided Circumcision
11 Completed
Has Results
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
Conditions: HIV;   Opioid Dependence
Interventions: Behavioral: Community-friendly Health Recovery Program;   Behavioral: Time-and-Attention-Matched Control Condition
12 Recruiting Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
Conditions: Risk Behavior;   Medication Adherence;   HIV
Interventions: Behavioral: 3H+ (Holistic Health for HIV);   Behavioral: HHRP+ (Holistic Health Recovery Program)
13 Recruiting Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: Rosuvastatin;   Other: Placebo
14 Recruiting Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care
Condition: HIV
Interventions: Behavioral: FAmily-CEntered Advance Care Planning;   Behavioral: Healthy Living Control
15 Completed HIV Prevention Among Vulnerable Male Youth
Conditions: Homosexuality, Male;   HIV;   Substance-related Disorders;   Sexual Dysfunctions, Psychological
Interventions: Behavioral: Group-based intervention - Experimental;   Behavioral: Group-based intervention - Control
16 Recruiting Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Conditions: HIV Infection;   Alcohol Use;   Bone Disease;   Substance-Related Disorders
Intervention:
17 Unknown  Atorvastatin for HAART Suboptimal Responders
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Other: 'atorvastatin, Lipitor®';   Drug: Placebo
18 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
19 Active, not recruiting Behavioral Intervention to Enhance HIV Test/Treat
Condition: HIV/AIDS
Interventions: Behavioral: Infectiousness Risk Reduction;   Behavioral: General Health Improvement
20 Completed A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg;   Drug: Calcium Carbonate  1200 mg;   Drug: Ferrous Fumarate 324 mg

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years